Global drug giant, AstraZeneca has submitted a supplemental new drug application (sNDA) to Japan’s Pharmaceuticals...
Singapore- Minerva Neurosciences, a clinical-stage biopharmaceutical company focused on the development of therapi...
Singapore- The European Commission (EC) has approved commercialization partner Ipsen's marketing application for C...
Singapore- Regeneron Pharmaceuticals and development partner Sanofi announce positive preliminary data from a...
Singapore- Dicerna Pharmaceutical’s drug recently received an orphan drug status designation for i...
Singapore- The U.S. Food and Drug Administration approved privately held US WorldMeds LLC's Lucemyra (lofexidine hydroch...
Singapore– Daré Bioscience, a clinical-stage women’s biopharmaceutical company has agreed t...
Kindred Biosciences, Inc. a biopharmaceutical company focused on saving and improving the lives of pets, announced that ...
Singapore – Shanghai-based Zai Lab Limited inks an exclusive license agreement with privately held Entasis Therape...
Pfizer recently announced that its lead Meningococcal Group B Vaccine TRUMENBA received Breakthrough Therapy designation...
Singapore - Zymeworks, a clinical-stage biopharmaceutical company developing multifunctional therapeutics, announced tha...
Singapore- Belgium based UCB announced an agreement to acquire the rights to Proximagen's Midazolam Nasal Spray (US...
Singapore- Johnson & Johnson will implement a new pricing and dosage scheme for cancer med IMBRUVICA (ibrutinib) con...
OBI Pharma, Inc., a Taiwan biopharma company announced that the U.S. Food and Drug Administration (FDA) has cleared an i...
Perrigo and its Israel based partner, Dexcel Pharma announced the launch of store brand omeprazole delayed release orall...
Pfizer recently announced that it has initiated a Phase 1b clinical trial for its mini-dystrophin gene therapy candidate...
Strides Shasun said its wholly-owned subsidiary has received approval from the US health regulator for Cyproheptadine Hy...
M&A deal making continues with Alexion Pharmaceuticals swapping up Wilson Therapeutics AB for USD 855 millio...
